TAP Block Timing Study
Transversus Abdominis Plane (TAP) Blocks in Bariatric and General Surgery: Does Timing Matter?
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Cheguevara Afaneh, MD
- Phone Number: +1 646 962 8462
- Email: cha9043@med.cornell.edu
Study Contact Backup
- Name: Hasan Ali
- Email: hoa4002@qatar-med.cornell.edu
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Recruiting
- Weill Cornell Medical College - NewYork-Presbyterian Hospital
-
Principal Investigator:
- Cheguevara Afaneh, MD
-
Contact:
- Hasan Ali
- Phone Number: (646) 962-8462
- Email: hoa4002@qatar-med.cornell.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged between 18 and 65 years
- Scheduled for elective bariatric surgery or other elective general abdominal surgeries
- Proficient in English sufficient to understand study procedures and communicate effectively
- Capable of providing informed consent
Exclusion Criteria:
- Individuals under 18 years of age (minors)
- Pregnant individuals
- Prisoners
- Individuals with cognitive impairments or otherwise unable to provide informed consent independently
- Individuals with known allergies or contraindications to local anesthetics used in TAP blocks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Pre-Incision
TAP block administration pre-incision
|
the TAP block is a regional anesthesia technique that targets the somatic nerves supplying the anterior abdominal wall.
|
|
Other: Post-Incision
TAP block administration post-incision
|
the TAP block is a regional anesthesia technique that targets the somatic nerves supplying the anterior abdominal wall.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean change in opioid consumption (MME) from index procedure to 90 days post-op
Time Frame: Up to 90 days post-operatively
|
Opioid dosage quantities will be measured in morphine milligram equivalents (MME)
|
Up to 90 days post-operatively
|
|
Change in Pain Scores from index procedure on a numerical rating scale
Time Frame: 1, 3, 6, 24, 48, and 72 hours postoperatively
|
Patient-reported pain on a scale of 1-10.
|
1, 3, 6, 24, 48, and 72 hours postoperatively
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1. Total Opioid Consumption in MME from Surgery to 90 Days Postoperatively
Time Frame: From end of surgery to 90 days post-op.
|
Sum of all opioid use from surgery to 90 days, in MME
|
From end of surgery to 90 days post-op.
|
|
Patient Satisfaction Score with Postoperative Pain Management at Discharge
Time Frame: At hospital discharge (within 3-5 days post-op)
|
Satisfaction score using a 5-point Likert scale survey before discharge.
|
At hospital discharge (within 3-5 days post-op)
|
|
Use of Non-Opioid Analgesics within 72 Hours
Time Frame: From end of surgery to 72 hours post-op
|
Count of participants receiving non-opioid pain medications (e.g.
acetaminophen, NSAIDs) within 72 hours post-op, including amount and type.
|
From end of surgery to 72 hours post-op
|
|
Number of Participants with TAP Block-Related Adverse Events
Time Frame: From TAP block administration to 90 days post-op.
|
Incidence of adverse events (e.g.
local anesthetic toxicity, infection, bleeding) related to TAP block.
|
From TAP block administration to 90 days post-op.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Cheguevara Afaneh, MD, Weill Medical College of Cornell University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 25-04028793
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.